Uroflowmetry and Nocturnal Enuresis

Active, not recruiting

• Conditions: Enuresis, Nocturnal
• Interventions: Drug: desmopressin melt form 120 μg; Drug: Desmopressin lyophilisate (Melt); Drug: Propiverine tablet

• Registration Number: NCT07028645
• Lead Sponsor: Furkan Adem Canbaz

Brief Summary

This study will evaluate the uroflowmetry parameters of patients which were treated for enuresis.

Detailed Description

A total of approximately 100 patients with enuresis will be evaluated retrospectively. Uroflowmetry parameters of these patients will be evaluated. For this purpose, patients will be divided to mainly three groups according to the treatment choices.

Study Timeline

• Study Start: 2022-08-20
• Primary Completion: 2024-09-01
• Status Verified: 2025-06
• Study First Submitted: 2025-06-11
• Study First Submitted QC: 2025-06-18
• Last Update Submitted: 2025-06-18
• Study First Posted: 2025-06-19
• Last Update Posted: 2025-06-24
• Study Completion: 2025-12-30

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Presence of enuresis nocturna
• Patients who have uroflowmetry test

Exclusion Criteria

• Presence of lower urinary tract symptoms
• Presence of anatomical or neurological problems
• Patients with missing data

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Desmopressin 120mcg	desmopressin melt form 120 μg	Patients treated with desmopressin 120 mcg
Desmopressin 240 mcg	Desmopressin lyophilisate (Melt)	Patients treated with desmopressin 240mcg
Desmopressin 240 mcg + anticholinergic	Propiverine tablet	Patients treated with desmopressin 240mcg + anticholinergic agent

Primary Outcome Measures

Name	Time	Method
Number of days without bedwetting	1 month	Achievement of bedwetting in one or less night of a month

Trial Locations

Locations (1)

Sancaktepe Sehit Prof dr Ilhan Varank Training and Research Hospital; 🇹🇷 Istanbul, Kadikoy, Turkey